Shares of AbbVie Inc. ABBV, +1.85% rose 1.85% to $154.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.48% rising 0.48% to 3,965.34 and the Dow Jones Industrial Average DJIA, +0.59% rising 0.59% to 33,745.69. This was the stock’s second consecutive day of gains. AbbVie Inc. closed $20.93 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock outperformed some of its competitors Friday, as Pfizer Inc. PFE, -0.21% fell 0.21% to $48.23, Eli Lilly & Co. LLY, +0.25% rose 0.25% to $361.67, and AstraZeneca PLC ADR AZN, +1.58% rose 1.58% to $65.07. Trading volume (5.7 M) remained 142,783 below its 50-day average volume of 5.8 M.